Filing Details

Accession Number:
0000899243-23-001039
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-05 18:18:02
Reporting Period:
2022-12-22
Accepted Time:
2023-01-05 18:18:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1633932 Essa Pharma Inc. EPIX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451935 Ross David Parkinson C/O Essa Pharma Inc.
999 West Broadway, Suite 720
Vancouver A1 V5Z 1K5
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-12-22 21,367 $2.39 53,475 No 4 P Direct
Common Shares Acquisiton 2022-12-30 3,067 $2.60 56,542 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.